KPTI vs MSFT: Which Stock is Better?
Side-by-side comparison of Karyopharm Therapeutics Inc and Microsoft Corporation in 2026
KPTI
Karyopharm Therapeutics Inc
$1.85
MSFT
Microsoft Corporation
$498.10
Key Metrics Comparison
| Metric | KPTI | MSFT | Winner |
|---|---|---|---|
| Market Cap | $205.55M | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | KPTI |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 13.6% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze KPTI
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KPTI or MSFT a better investment?
Comparing KPTI and MSFT: Karyopharm Therapeutics Inc has a market cap of $205.55M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KPTI and MSFT?
KPTI (Karyopharm Therapeutics Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KPTI or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KPTI or MSFT?
MSFT has higher revenue growth at 18.4% vs 13.6% for KPTI.
Which company is more profitable: KPTI or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for KPTI.
Which is the larger company: KPTI or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $205.55M for KPTI.
Should I buy KPTI or MSFT in 2026?
Both KPTI and MSFT have investment merit. KPTI trades at $1.85 while MSFT trades at $498.10. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KPTI and MSFT stock?
Key differences: Market Cap ($205.55M vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (13.6% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy KPTI or MSFT in 2026?
The choice between KPTI and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between KPTI and MSFT?
KPTI (Karyopharm Therapeutics Inc) has a market cap of $205.55M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.